A business in context

ATNM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-14 · 0001213900-26-110340

  2. DEF 14A · Proxy statement

    Report date 2026-11-25 · 0001213900-26-110022

  3. 8-K · Current report

    Report date 2026-10-14 · 0001213900-26-109884 · Items 5.02,7.01,9.01

  4. 4 · Ownership change

    Report date 2026-09-02 · 0001213900-26-097745

  5. 4 · Ownership change

    Report date 2026-09-02 · 0001213900-26-097744

  6. 4 · Ownership change

    Report date 2026-09-02 · 0001213900-26-097742

  7. 4 · Ownership change

    Report date 2026-09-02 · 0001213900-26-097741

  8. 4 · Ownership change

    Report date 2026-09-02 · 0001213900-26-097740

  9. 4 · Ownership change

    Report date 2026-09-02 · 0001213900-26-097739

  10. 8-K · Current report

    Report date 2026-08-12 · 0001213900-26-090232 · Items 3.01,7.01,9.01

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-086769

  12. 8-K · Current report

    Report date 2026-06-18 · 0001213900-26-070193 · Items 8.01

  13. 8-K · Current report

    Report date 2026-05-27 · 0001213900-26-062935 · Items 3.01,7.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-053980

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-036504

  16. 8-K/A · Current report

    Report date 2025-11-26 · 0001213900-26-034807 · Items 5.07

  17. 8-K · Current report

    Report date 2026-02-11 · 0001213900-26-016559 · Items 5.02

  18. 8-K · Current report

    Report date 2025-11-26 · 0001213900-25-115586 · Items 5.02,5.07

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-110979

  20. DEF 14A · Proxy statement

    Report date 2025-11-26 · 0001213900-25-106706

  21. 4 · Ownership change

    Report date 2025-08-18 · 0001213900-25-079019

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001213900-25-073743

  23. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001213900-25-041614

  24. 8-K · Current report

    Report date 2025-05-08 · 0001213900-25-041582 · Items 4.01,9.01

  25. 10-K · Annual report

    Report date 2024-12-31 · 0001213900-25-026371

  26. 8-K · Current report

    Report date 2024-11-27 · 0001213900-24-103498 · Items 5.02,5.07

  27. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001213900-24-098534

  28. SC 13G/A · Ownership disclosure

    0000932471-24-000829

  29. SC 13G/A · Ownership disclosure

    0000921895-24-002532

  30. 8-K · Current report

    Report date 2024-11-01 · 0001213900-24-094622 · Items 5.02,8.01,9.01

  31. DEF 14A · Proxy statement

    Report date 2024-11-27 · 0001213900-24-094619

  32. SC 13G/A · Ownership disclosure

    0000932471-24-000275

  33. SC 13G · Ownership disclosure

    0000932471-24-000238

  34. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001213900-24-065239

  35. 8-K · Current report

    Report date 2024-08-05 · 0001213900-24-064993 · Items 7.01,9.01

  36. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001213900-24-036699

  37. 10-K · Annual report

    Report date 2023-12-31 · 0001213900-24-028038

  38. SC 13G/A · Ownership disclosure

    0000921895-24-000320

  39. SC 13G · Ownership disclosure

    0001086364-24-005168

  40. 8-K · Current report

    Report date 2023-11-30 · 0001213900-23-092089 · Items 5.02,5.07

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 13 transaction rows13AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

13 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-02
2026-09-04
Nicholson, C. DavidA · Grant / award
Acquired
Common Stock62800.00.0
2026-09-02
2026-09-04
Nicholson, C. DavidA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
94200.00.0
2026-09-02
2026-09-04
Shetty AjitA · Grant / award
Acquired
Common Stock61600.00.0
2026-09-02
2026-09-04
Shetty AjitA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
92400.00.0
2026-09-02
2026-09-04
Almenoff June Sherie
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock18000.00.0
2026-09-02
2026-09-04
Almenoff June Sherie
10b5-1 checkbox reported
A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
27000.00.0
2026-09-02
2026-09-04
SETH SANDESHA · Grant / award
Acquired
Common Stock1027274.00.0
2026-09-02
2026-09-04
SETH SANDESHA · Grant / award
Acquired
Common Stock753600.00.0
2026-09-02
2026-09-04
SETH SANDESHA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1130400.00.0
2026-09-02
2026-09-04
Steinhart Richard IA · Grant / award
Acquired
Common Stock62800.00.0
2026-09-02
2026-09-04
Steinhart Richard IA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
94200.00.0
2026-09-02
2026-09-04
Chell Jeffrey W.A · Grant / award
Acquired
Common Stock61600.00.0
2026-09-02
2026-09-04
Chell Jeffrey W.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
92400.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001388320Actinium Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Cactus Ventures, Inc. · former SEC name · 2007-02-05 to 2013-03-29

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2023-12-31$81.0K$89.6K
2022-12-31$1.03M$1.19M
2021-12-31$1.14M$1.42M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗